Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals is a vertically integrated pharmaceutical company that produces generic medicines and active pharmaceutical ingredients.

Metric
Company Name	Alembic Pharmaceuticals Limited
Symbol	APLLTD
MSH ID	COM:ALEMBICPHARMACEUTICALS
Market	STOCKS
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Country	IN
Stage
Employee Count	14.86K
Website	alembicpharmaceuticals.com
LinkedIn
Founders

Metric
Market Cap	2.32B
Enterprise Value
Monthly Web Traffic	61.60K
Web Traffic Growth	5.79
Valuation
Raised Capital

Metric
Revenue	735.36M
Revenue (LTM)
Revenue (NTM)
Gross Profit	329.93M
EBITDA	110.19M
Operating Income	78.00M
Net Income	72.70M
EPS	0.37
Diluted EPS	0.37
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.71
Operating Profit Margin	0.11
EBITDA Margin	0.15
Net Profit Margin	0.10
Return on Equity	0.27
Return on Assets	0.10
Return on Capital Employed	0.14

COM:ALEMBICPHARMACEUTICALS

Alembic Pharmaceuticals

Last Close

1,041.85

25/11 09:40

Market Cap

196.41B

Beta: -

Volume Today

140.60K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	35.67
P/B Ratio	4.24
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.91
EV Multiple	25.03

Metric
Days Sales Outstanding	69.85
Days Payables Outstanding	157.80
Days Inventory Outstanding	274.37
Operating Cycle	334.43
Cash Conversion Cycle	211.62
Asset Turnover	0.98

Metric
Operating Cash Flow	89.23M
Free Cash Flow	50.57M
Cash Flow to Debt	0.79
Operating Cash Flow/Sales	0.09
Free Cash Flow Yield

Metric
Cash & Equivalents	14.94M
Accounts Receivable	4.61M
Inventory	194.04M
Goodwill
Debt to Capitalization	0.10
Debt to Assets	0.13
Current Ratio	1.73
Quick Ratio	0.99

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.02
SG&A to Revenue